Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC.
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership...
Cerebain Biotech Corp. (OTC: CBBT) (the “Company” or “Cerebain”) today provided an update pertaining to the Share Exchange Agreement with PKG, Inc., an Idaho Corporation (PKG) and the equity holders...
Cerebain Biotech Corp. (OTC: CBBT), today announced that PKG, Inc. is to become the key manufacturer for ClearMask, LLC and Xometry.
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announces a General Business Update.
BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020 / NMS Consulting, Inc. ("NMS") is pleased to announce that it has been selected as strategic advisor by Cerebain Biotech Cop. (OTCPINK:CBBT) ("Cerebain")...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has entered into a Letter of Intent to purchase the assets of PKG, Inc. (PKG).